Institutions / Baker Bros. Advisors LP / Holdings
Back to Baker Bros. Advisors LP

Baker Bros. Advisors LP

All holdings · as of Mar 31, 2026

84 positions

CompanyClassValueShares% of portfolio
Celldex Therapeutics, Inc.—$21.11M665,3700.1%
Neurogene Inc.NGNECommon Stock$19.99M991,6910.1%
Evommune, Inc.EVMNCommon Stock$19.48M847,3900.1%
Tectonic Therapeutic, Inc.TECXCommon Stock$18.79M607,7880.1%
Contineum Therapeutics, Inc.—$18.56M1,420,8380.1%
argenx SE—$18.38M25,1740.1%
CERUS CORP—$18.22M10,008,3450.1%
Taysha Gene Therapies, Inc.TSHACommon Stock$17.90M4,004,7560.1%
Aktis Oncology, Inc.AKTSCommon Stock$17.82M996,3510.1%
Generate Biomedicines, Inc.—$17.80M1,423,6020.1%
Sionna Therapeutics, Inc.—$16.04M400,0000.1%
Dyne Therapeutics, Inc.—$14.75M813,4490.1%
Xencor Inc—$13.29M1,102,1060.1%
COMPASS Pathways plcCMPSADR$12.97M2,344,7200.1%
Relay Therapeutics, Inc.—$11.54M1,160,1170.1%
SERA PROGNOSTICS, INC.SERACommon Stock$11.16M5,498,1700.1%
BioNTech SEBNTXADR$10.64M119,7430.1%
Pharvaris N.V.—$10.59M375,0000.1%
Arcus Biosciences, Inc.—$8.98M415,6210.1%
MAPLIGHT THERAPEUTICS INCMPLTCommon Stock$7.41M364,7050.0%
Absci Corp—$6.40M2,134,8030.0%
Wave Life Sciences Ltd.—$5.96M822,6380.0%
vTv Therapeutics Inc.—$5.88M148,3140.0%
EIKON THERAPEUTICS, INC.—$5.88M555,5550.0%
Protara Therapeutics, Inc.—$5.06M971,6140.0%
Sagimet Biosciences Inc.SGMTCommon Stock$4.98M952,9960.0%
LB PHARMACEUTICALS INCLBRXCommon Stock$4.93M200,0000.0%
Verastem, Inc.—$3.10M584,7570.0%
TScan Therapeutics, Inc.TCRXCommon Stock$2.81M2,784,7920.0%
Skye Bioscience, Inc.SKYECommon Stock$968.1K1,575,2430.0%
Sana Biotechnology, Inc.—$894.2K310,4830.0%
Aligos Therapeutics, Inc.—$617.1K83,0550.0%
Tyra Biosciences, Inc.—$406.2K10,6070.0%
Surrozen, Inc.—$13.3K833,3330.0%
← PrevPage 2 of 2Next →